Status:
COMPLETED
A Comparative Study of Intrathecal Dexmedetomidine and Fentanyl As Additives to Bupivacaine in Pott's Fracture
Lead Sponsor:
Ain Shams University
Conditions:
Post Operative Pain
Eligibility:
All Genders
21-55 years
Phase:
PHASE1
Brief Summary
The aim of this study is to compare the addition of intrathecal dexmedetomidine or fentanyl as adjuvants to hyperbaric bupivacaine in the onset and duration of sensory and motor block, and postoperati...
Detailed Description
The aim of this study is to compare the addition of intrathecal dexmedetomidine or fentanyl as adjuvants to hyperbaric bupivacaine in the onset and duration of sensory and motor block, and postoperati...
Eligibility Criteria
Inclusion
- • ASA I or ASA II patients Scheduled for pott's, of either sex.
- Age 21-55 years.
- Height 160 to 190 cm.
- BMI ≤40.
- Procedure duration ≤ 90 minutes
Exclusion
- • Patients with known neurologic and psychiatric illness.
- Contraindications for spinal anesthesia as patient refusal, bleeding or coagulation test abnormalities, local skin infection at spinal lumbar region, raised intracranial pressure and hypovolemia.
- Spine abnormalities.
- Systemic disorders like hematological, respiratory, cardiac, renal or hepatic insufficiency.
- Allergy to any of the drugs used in the study.
- Women with pregnancy and lactation
Key Trial Info
Start Date :
January 15 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 5 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06502262
Start Date
January 15 2024
End Date
September 5 2024
Last Update
February 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ain Shams University
Cairo, Abbassia, Egypt, 00202